GlassScriptPhysician profile
Morgan H Jones
NPI 1518996073
$31,898.81
in general payments reported to CMS, 2019-2025
9 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2021: $9,850 · 2023: $189 · 2024: $21K · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,149 · Honoraria: $7,125 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,875 · Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,148.70 |
| Honoraria | $7,125.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,875.00 |
| Food and Beverage | $677.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $21,292.53 | 2024 | |
| Regeneron Pharmaceuticals, INC. | $9,600.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $249.78 | 2021 | |
| Miach Orthopaedics, INC. | $179.83 | 2024 | |
| Davol INC. | $164.84 | 2025 | Arista |
| Nuvasive, INC. | $154.18 | 2023 | Pulse, Xlif, Reline |
| Smith+Nephew, INC. | $117.79 | 2019-2023 | Acufex, Spatial Frame |
| Sanofi-Aventis U.S. LLC | $93.94 | 2019 | |
| Stryker Corporation | $45.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.